M&A Deal Summary

Evonik Industries Acquires Surmodics Pharmaceuticals

On November 2, 2011, Evonik Industries acquired life science company Surmodics Pharmaceuticals from SurModics for 30M USD

Acquisition Highlights
  • This is Evonik Industries’ 2nd transaction in the Life Science sector.
  • This is Evonik Industries’ 3rd largest (disclosed) transaction.
  • This is Evonik Industries’ 3rd transaction in the United States.
  • This is Evonik Industries’ 1st transaction in Alabama.

M&A Deal Summary
Date 2011-11-02
Target Surmodics Pharmaceuticals
Sector Life Science
Buyer(s) Evonik Industries
Sellers(s) SurModics
Deal Type Divestiture
Deal Value 30M USD

Target

Surmodics Pharmaceuticals

Birmingham, Alabama, United States
Surmodics Pharmaceuticals is a drug delivery company that provides its proprietary polymer based technologies to companies developing improved pharmaceutical products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Evonik Industries

Essen, Germany
Category Company
Founded 1873
Sector Diversified
Employees33,090
Revenue 15.3B EUR (2023)
DESCRIPTION

Evonik Industries is an industrial corporation with worldwide operations grouped in three business areas Chemicals, Energy and Real Estate which are positioned at the forefront of their market segments. It is a global leader in specialty chemicals (former Degussa), an expert in power generation from hard coal and renewable energies (former STEAG) and one of Germany's largest privately owned residential real estate companies. Evonik Industries was founded in 1873 and is based in Essen, Germany.

DEAL STATS #
Overall 5 of 12
Sector (Life Science) 2 of 3
Type (Divestiture) 2 of 3
State (Alabama) 1 of 1
Country (United States) 3 of 6
Year (2011) 2 of 2
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-29 Orion Engineered Carbons

Frankfurt, Germany

Orion Engineered Carbons GmbH a producer of carbon black for application in specialty pigments and for the reinforcement of various rubber-based products.

Sell €900M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-04 Silbond

Weston, Michigan, United States

Silbond Corp. is a supplier of tetra ethyl ortho silicate (TEOS), a specialty chemical sold to an international customer base in the semiconductor, electronics, industrial protective coating, investment casting and chemical processing industries.

Buy -

Seller(S) 1

SELLER

SurModics

Eden Prairie, Minnesota, United States
Category Company
Founded 1979
Sector Medical Products
Revenue 133M USD (2023)
DESCRIPTION

SurModics provides surface modification coating technologies and in vitro diagnostic (IVD) products to the healthcare industry. Its two core businesses include: Medical Device Coatings – lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and advanced drug delivery systems; and In Vitro Diagnostics (IVD) – immunoassay reagents that improve the performance of in vitro diagnostic tests as well as custom coatings and stabilization products for Molecular Diagnostic applications. Surmodics was founded in 1979 and is based in Eden Prairie, Minnesota.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Alabama) 1 of 1
Country (United States) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-08-14 SurModics IVD

Eden Prairie, Minnesota, United States

SurModics IVD, Inc. is a manufacturer, and marketer of colorimetric and chemiluminescent substrates.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-20 Creagh Medical

Ballinasloe, Ireland

Creagh Medical Ltd. is a developer and manufacturer of percutaneous transluminal angioplasty (PTA) balloon catheters.

Buy €30M
Mergr

Product

Company

Legal